earnings
confidence high
sentiment neutral
materiality 0.75
ICU Medical Q1 revenue $543M, GAAP net loss $38.1M, adjusted EPS $1.82
ICU MEDICAL INC/DE
2022-Q1 EPS reported
-$1.61
revenue$543,122,000
- Revenue $543.1M, up 71% from $318.0M in Q1 2021.
- GAAP net loss of $38.1M ($1.61 per diluted share) vs net income of $23.7M ($1.09) in Q1 2021.
- Adjusted diluted EPS $1.82, up from $1.62; adjusted EBITDA $84.9M vs $57.8M.
- GAAP gross margin declined to 31% from 35% in Q1 2021.